These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 2013815

  • 21. Effect of nicotinic acid on exogenous myocardial glucose utilization.
    Stone CK, Holden JE, Stanley W, Perlman SB.
    J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
    [Abstract] [Full Text] [Related]

  • 22. Routine 18F-2-deoxy-2-fluoro-D-glucose (18F-FDG) myocardial tomography using a normal large field of view gamma-camera.
    Höflin F, Ledermann H, Noelpp U, Weinreich R, Rösler H.
    Angiology; 1989 Dec; 40(12):1058-64. PubMed ID: 2596740
    [Abstract] [Full Text] [Related]

  • 23. [PET assessment of myocardial viability with glucose loading and fasting FDG images].
    Niwayama H, Yoshida K, Kagaya A, Himi T, Masuda Y, Inagaki Y, Ito Y, Uematsu S, Imazeki K, Arimizu N.
    Kaku Igaku; 1990 Mar; 27(3):285-8. PubMed ID: 2352373
    [Abstract] [Full Text] [Related]

  • 24. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism.
    Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR.
    J Nucl Med; 1982 Jul; 23(7):577-86. PubMed ID: 6979614
    [Abstract] [Full Text] [Related]

  • 25. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA, Colgan M, Baxter LR, Quintana J, Siegel S, Chatziioannou A, Cherry SR, Mazziotta JC, Phelps ME.
    Am J Primatol; 1997 Jul; 42(3):215-24. PubMed ID: 9209586
    [Abstract] [Full Text] [Related]

  • 26. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A.
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P.
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [Abstract] [Full Text] [Related]

  • 28. [18F]FDG in measuring myocardial glucose uptake.
    Knuuti J, Nuutila P, Voipio-Pulkki LM.
    Circulation; 1995 Nov 15; 92(10):3146-8. PubMed ID: 7586291
    [No Abstract] [Full Text] [Related]

  • 29. A new double modeling approach for dynamic cardiac PET studies using noise and spillover contaminated LV measurements.
    Feng D, Li X, Huang SC.
    IEEE Trans Biomed Eng; 1996 Mar 15; 43(3):319-27. PubMed ID: 8682545
    [Abstract] [Full Text] [Related]

  • 30. Myocardial 18F-FDG-PET. Experiences with the euglycemic hyperinsulinemic clamp technique.
    Locher JT, Frey LD, Seybold K, Jenzer H.
    Angiology; 1995 Apr 15; 46(4):313-20. PubMed ID: 7726451
    [Abstract] [Full Text] [Related]

  • 31. Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET.
    Herholz K.
    Eur J Nucl Med; 1988 Apr 15; 14(9-10):477-84. PubMed ID: 3265103
    [Abstract] [Full Text] [Related]

  • 32. Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET.
    Blanksma PK, Willemsen AT, Meeder JG, de Jong RM, Anthonio RL, Pruim J, Vaalburg W, Lie KI.
    J Nucl Med; 1995 Jan 15; 36(1):153-8. PubMed ID: 7799070
    [Abstract] [Full Text] [Related]

  • 33. Impact of Image-Derived Input Function and Fit Time Intervals on Patlak Quantification of Myocardial Glucose Uptake in Mice.
    Thackeray JT, Bankstahl JP, Bengel FM.
    J Nucl Med; 2015 Oct 15; 56(10):1615-21. PubMed ID: 26272811
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of reverse redistribution on 24-hour delayed imaging of exercise thallium-201 myocardial SPECT: comparison with myocardial fluorine-18-FDG-PET imaging and left ventricular wall motion.
    Ohte N, Hashimoto T, Banno T, Narita H, Kobayashi K, Akita S, Fujinami T.
    J Nucl Med; 1995 Jan 15; 36(1):86-92. PubMed ID: 7799089
    [Abstract] [Full Text] [Related]

  • 35. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
    Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H.
    Circulation; 1995 May 01; 91(9):2435-44. PubMed ID: 7729031
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
    Ashmarin IIu.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984 May 01; 7(2):103-7. PubMed ID: 6391515
    [No Abstract] [Full Text] [Related]

  • 38. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H.
    Z Kardiol; 1994 Feb 01; 83(2):124-31. PubMed ID: 8165842
    [Abstract] [Full Text] [Related]

  • 39. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J.
    J Nucl Med; 1993 Dec 01; 34(12):2068-75. PubMed ID: 8254389
    [Abstract] [Full Text] [Related]

  • 40. Temporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucose.
    Nguyêñ VT, Mossberg KA, Tewson TJ, Wong WH, Rowe RW, Coleman GM, Taegtmeyer H.
    Am J Physiol; 1990 Oct 01; 259(4 Pt 2):H1022-31. PubMed ID: 2221110
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.